<DOC>
	<DOCNO>NCT02660593</DOCNO>
	<brief_summary>MedlinePlus related topic : Blood Sugar Primary Outcome Measures : - Fast glucose HbA1c change baseline end study [ Time Frame : From baseline 30 100 day ] - [ Designated safety issue : No ] - Successful rate blood glucose control ( proportion patient HbA1c &lt; 7 % ) [ Time Frame : From baseline 30 day 100 day ] [ Designated safety issue : No ] Secondary Outcome Measures : â€¢ To evaluate change quality life 1 month health questionnaire SF-36 [ Time Frame : From baseline month 1 ] [ Designated safety issue : No ]</brief_summary>
	<brief_title>Efficacy Safety ofSanGrow Decoction Patients With Diabetes</brief_title>
	<detailed_description>This study aim evaluate safety efficacy Sangrow Decotion , diet exercise treatment type 2 diabetes . Previous study show therapeutic regimen safe effective .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Type II diabetes mellitus patient receive medical treatment 3 month Patients willing sign write informed consent form Patients unable unwilling comply requirement protocol Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study Life expectancy &lt; 6 month due concomitant illness .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Chinese medicine</keyword>
	<keyword>exercise</keyword>
	<keyword>diet</keyword>
</DOC>